Cochlear profit up
Tuesday, 12 August, 2008
In a difficult year, Cochlear [ASX: COH] has posted excellent year-end results, with net profit up 15 per cent from last year.
Total revenue was $601.7 million, up eight per cent, for a net profit after tax of $115.2 million, slightly below forecasts.
Sales revenue has grown 18 per cent, after accounting for the appreciation of the Australian dollar.
Shareholders will be rewarded with a dividend of 80 cents per share.
The company said it expected double-digit growth again next year.
Organoid platform enables closer study of bat-borne viruses
Reconstructing bat organ physiology in the lab lets scientists explore how zoonotic viruses work...
Global study finds 250 genes linked to OCD
Researchers say they have found the genes linked to obsessive compulsive disorder (OCD), after...
TGA approves therapy for paediatric growth hormone deficiency
The TGA has approved SKYTROFA as a treatment for growth failure in children and adolescents aged...
